Advertisement
Advertisement
ALGS
Aligos Therapeutics, Inc. Common Stock
5.68
USDSponsored
+0.19
+3.46%
Sep 22, 15:59 UTC -4
Closed
After-Market
5.74
+0.06
+1.06%
Aligos Therapeutics, Inc. Common Stock Financial Snapshot
| Market Cap | 35.84M |
| Beta | 2.34 |
| Earnings Per Share (EPS) | -7.30 |
| Price-to-Book (P/B) Ratio | 1.02 |
| Operating Margin | -241.01% |
| Total Debt/Equity (D/E) | 0.20% |
| P/E Ratio | -- |
| Return on Equity (ROE) | -160.72% |
| Current Ratio | 2.19% |
| Free Cash Flow | -48.15M |
